Latest Neuropathic pain Stories
Novel Product Being Studied to Treat Neuropathic Pain. NEW YORK, Dec. 22, 2014 /PRNewswire/ -- Relmada Therapeutics, Inc.
Follows Positive Phase 2 Data Showing Rapid, Robust and Sustained Antidepressant Effect of Adjunctive GLYX-13 in Patients with Major Depressive Disorder EVANSTON, Ill., Dec.
Novel Product Virtually Devoid of Opioid Activity Being Studied in Neuropathic Pain. NEW YORK, Dec. 2, 2014 /PRNewswire/ -- Relmada Therapeutics, Inc.
PETACH TIKVA, Israel, Dec. 1, 2014 /PRNewswire/ -- Can-Fite BioPharma Ltd.
MENLO PARK, Calif., Nov.
TARRYTOWN, N.Y., Oct.
FREDERICK, Md., Oct.
RADNOR, Pa., Oct.
Stagnation in the Total Pain Market During the Next Fifteen Years Masks Underlying Changes in Market Dynamics, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct.
- The act of sweetening by admixture of some saccharine substance.